Canica is a venture capital fund based in Oslo, Norway, specializing in biotechnology, health technology, and deep technology. It focuses on Series B stage companies, providing both capital and strategic guidance. Notable investments include Oncoinvent. Founded in 1985 by Stein Erik Hagen, Canica has become one of Norway's largest privately-owned investment firms. Beyond technology, its expertise covers business development and finance, aiming for long-term value and job creation. Canica is committed to supporting its brands, employees, and the broader community.
